Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electrophysiological and Echocardiographic PREDICTors of Atrial Fibrillation Following Interventional Closure of Patent Foramen Ovale in Cryptogenic Stroke: PREDICT-AF-PFO

NCT04898361 is registered in ClinicalTrials.gov with University Hospital, Saarland as lead sponsor.

NCT NCT04898361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04898361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electrophysiological and Echocardiographic PREDICTors of Atrial Fibrillation Following Interventional Closure of Patent Foramen Ovale in Cryptogenic Stroke: PREDICT-AF-PFO
Lead sponsor
University Hospital, Saarland
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2020
Completion date
June 30, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation new onset, embolic stroke of undetermined source, patent foramen ovale